Clinical Trial Update: Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating humanized CD19-specific CAR T cells for relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Humanized CD19-specific CAR T cells

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING